Literature DB >> 29527285

Narrow-Spectrum Antibacterial Agents.

Roberta J Melander1, Daniel V Zurawski2, Christian Melander1.   

Abstract

While broad spectrum antibiotics play an invaluable role in the treatment of bacterial infections, there are some drawbacks to their use, namely selection for and spread of resistance across multiple bacterial species, and the detrimental effect they can have upon the host microbiome. If the causitive agent of the infection is known, the use of narrow-spectrum antibacterial agents has the potential to mitigate some of these issues. This review outlines the advantages and challenges of narrow-spectrum antibacterial agents, discusses the progress that has been made toward developing diagnostics to enable their use, and describes some of the narrow-spectrum antibacterial agents currently being investigated against some of the most clinically important bacteria including Clostridium difficile, Mycobacterium tuberculosis and several ESKAPE pathogens.

Entities:  

Year:  2017        PMID: 29527285      PMCID: PMC5839511          DOI: 10.1039/C7MD00528H

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  86 in total

1.  Design and recombination expression of a novel plectasin-derived peptide MP1106 and its properties against Staphylococcus aureus.

Authors:  Xintao Cao; Yong Zhang; Ruoyu Mao; Da Teng; Xiumin Wang; Jianhua Wang
Journal:  Appl Microbiol Biotechnol       Date:  2014-09-27       Impact factor: 4.813

2.  Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.

Authors:  Erin E Gill; Octavio L Franco; Robert E W Hancock
Journal:  Chem Biol Drug Des       Date:  2015-01       Impact factor: 2.817

Review 3.  Antibiotics: the changing regulatory and pharmaceutical industry paradigm.

Authors:  Richard Bax; Samantha Green
Journal:  J Antimicrob Chemother       Date:  2015-01-28       Impact factor: 5.790

Review 4.  MALDI-TOF MS for the diagnosis of infectious diseases.

Authors:  Robin Patel
Journal:  Clin Chem       Date:  2014-10-02       Impact factor: 8.327

5.  The Challenge of Overcoming Antibiotic Resistance: An Adjuvant Approach?

Authors:  Roberta J Melander; Christian Melander
Journal:  ACS Infect Dis       Date:  2017-05-26       Impact factor: 5.084

6.  Preliminary structure-activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.

Authors:  Oluseye K Onajole; Marco Pieroni; Suresh K Tipparaju; Shichun Lun; Jozef Stec; Gang Chen; Hendra Gunosewoyo; Haidan Guo; Nicole C Ammerman; William R Bishai; Alan P Kozikowski
Journal:  J Med Chem       Date:  2013-05-03       Impact factor: 7.446

Review 7.  Ridinilazole: a novel therapy for Clostridium difficile infection.

Authors:  Richard J Vickers; Glenn Tillotson; Ellie J C Goldstein; Diane M Citron; Kevin W Garey; Mark H Wilcox
Journal:  Int J Antimicrob Agents       Date:  2016-05-30       Impact factor: 5.283

Review 8.  Antibacterials Developed to Target a Single Organism: Mechanisms and Frequencies of Reduced Susceptibility to the Novel Anti-Clostridium difficile Compounds Fidaxomicin and LFF571.

Authors:  Jennifer A Leeds
Journal:  Cold Spring Harb Perspect Med       Date:  2016-02-01       Impact factor: 6.915

Review 9.  Risks of Antibiotic Exposures Early in Life on the Developing Microbiome.

Authors:  Anjelique Schulfer; Martin J Blaser
Journal:  PLoS Pathog       Date:  2015-07-02       Impact factor: 6.823

10.  Identification of the ESKAPE pathogens by mass spectrometric analysis of microbial membrane glycolipids.

Authors:  Lisa M Leung; William E Fondrie; Yohei Doi; J Kristie Johnson; Dudley K Strickland; Robert K Ernst; David R Goodlett
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

View more
  39 in total

Review 1.  Signed, Sealed, Delivered: Conjugate and Prodrug Strategies as Targeted Delivery Vectors for Antibiotics.

Authors:  Ana V Cheng; William M Wuest
Journal:  ACS Infect Dis       Date:  2019-04-10       Impact factor: 5.084

Review 2.  Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.

Authors:  Yu-Xuan Ma; Chen-Yu Wang; Yuan-Yuan Li; Jing Li; Qian-Qian Wan; Ji-Hua Chen; Franklin R Tay; Li-Na Niu
Journal:  Adv Sci (Weinh)       Date:  2019-12-05       Impact factor: 16.806

3.  Phage-Related Ribosomal Protease (Prp) of Staphylococcus aureus: In Vitro Michaelis-Menten Kinetics, Screening for Inhibitors, and Crystal Structure of a Covalent Inhibition Product Complex.

Authors:  Julia A Hotinger; Heather A Pendergrass; Darrell Peterson; H Tonie Wright; Aaron E May
Journal:  Biochemistry       Date:  2022-06-22       Impact factor: 3.321

Review 4.  Empiric Antibiotics in COVID 19: A Narrative Review.

Authors:  Elvina C Lingas
Journal:  Cureus       Date:  2022-06-02

5.  Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli.

Authors:  Amit Gaurav; Varsha Gupta; Sandeep K Shrivastava; Ranjana Pathania
Journal:  Commun Biol       Date:  2021-05-10

6.  Pathogen-specific antimicrobials engineered de novo through membrane-protein biomimicry.

Authors:  Andrew W Simonson; Agustey S Mongia; Matthew R Aronson; John N Alumasa; Dennis C Chan; Atip Lawanprasert; Michael D Howe; Adam Bolotsky; Tapas K Mal; Christy George; Aida Ebrahimi; Anthony D Baughn; Elizabeth A Proctor; Kenneth C Keiler; Scott H Medina
Journal:  Nat Biomed Eng       Date:  2021-01-04       Impact factor: 25.671

7.  Risk of antibiotic treatment failure in premenopausal women with uncomplicated urinary tract infection.

Authors:  Anne M Butler; Michael J Durkin; Matthew R Keller; Yinjiao Ma; Vikas R Dharnidharka; William G Powderly; Margaret A Olsen
Journal:  Pharmacoepidemiol Drug Saf       Date:  2021-04-13       Impact factor: 2.732

Review 8.  Metallotherapeutics development in the age of iron-clad bacteria.

Authors:  Garrick Centola; Fengtian Xue; Angela Wilks
Journal:  Metallomics       Date:  2020-12-23       Impact factor: 4.526

9.  Appropriateness of Antibiotic Prescription for Prophylactic Purposes among Italian Dental Practitioners: Results from a Cross-Sectional Study.

Authors:  Aida Bianco; Vincenza Cautela; Francesco Napolitano; Francesca Licata; Maria Pavia
Journal:  Antibiotics (Basel)       Date:  2021-05-08

10.  The use of antibiotics in COVID-19 management: a rapid review of national treatment guidelines in 10 African countries.

Authors:  Yusuff Adebayo Adebisi; Nafisat Dasola Jimoh; Isaac Olushola Ogunkola; Theogene Uwizeyimana; Alaka Hassan Olayemi; Nelson Ashinedu Ukor; Don Eliseo Lucero-Prisno
Journal:  Trop Med Health       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.